After Launching Corporate Venture Fund, WuXi Shifts Attention To China’s Domestic Market: China Earnings Roundup (Part 2)
This article was originally published in PharmAsia News
Executive Summary
China’s leading CRO grows revenues 24% in Q3, and establishes corporate venture fund to invest in homegrown innovation